MEDIPHARM LABS CORP (MEDIF:OTCMKTS)
$0.0531 0.0001 (0.1887%)
Analysed MEDIPHARM LABS CORP (MEDIF:OTCMKTS) News Sources
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
30-03-2026
yahoo.com
MediPharm Labs Corp (MEDIF) Q4 2025 Earnings Call Highlights: Strong International Growth ...
30-03-2026
yahoo.com
3 TSX Penny Stocks With Market Caps Over CA$20M To Consider
24-04-2026
yahoo.com
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
27-04-2026
yahoo.com
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
08-05-2026
yahoo.com
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
13-05-2026
yahoo.com
MediPharm Labs Reports Q1 2026 Results: Full Earnings Call Transcript
13-05-2026
yahoo.com
Transcript: MediPharm Labs Q1 2026 Earnings Conference Call
13-05-2026
yahoo.com
MediPharm Labs Corp (MEDIF) Q1 2026 Earnings Call Highlights: Strategic International Expansion ...
13-05-2026
yahoo.com
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
28-05-2026
yahoo.com
What is the current price of MEDIPHARM LABS CORP (MEDIF:OTCMKTS)?
The current price of MEDIPHARM LABS CORP (MEDIF:OTCMKTS) is $0.0531.
MEDIPHARM LABS CORP (MEDIF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDIPHARM LABS CORP (MEDIF:OTCMKTS) since the previous trading day is $0.0001.
MEDIPHARM LABS CORP (MEDIF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDIPHARM LABS CORP (MEDIF:OTCMKTS) since the previous trading day is 0.1887%.
What is the most recent average sentiment score for MEDIPHARM LABS CORP (MEDIF:OTCMKTS)?
The most recent average sentiment score for MEDIPHARM LABS CORP (MEDIF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for MEDIPHARM LABS CORP (MEDIF:OTCMKTS)?
The most recent sentiment for MEDIPHARM LABS CORP (MEDIF:OTCMKTS) is .
SEC-8K** Filing Available For MEDIPHARM LABS CORP (MEDIF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.